






Both the premature and age-induced ovarian failure are 
associated with significant medical and quality of life 
complications. Moreover, millions of children and 
adults suffer from iatrogenically-induced premature 
gonadal failure as a result of chemotherapy treatments. 
In the case of chemotherapy, commonly used cancer 
drugs such as doxorubicin or cyclophosphamide result 
in apoptotic death of primordial follicle reserve [1-3], 
probably by inducing double strand DNA breaks 
concurrent with  intense activation of ATM-mediated 
DNA repair pathways (unpublished data). Clinically, 
females who receive similar cancer drugs and who do 
not immediately become menopausal will experience 
premature menopause because of the diminishment of 
ovarian reserve. The prevailing dogma dictates that the 
primordial follicle reserve is fixed in utero and any 
insult reducing such reserve causes irreversible harm as 
oocyte regeneration is not possible in postnatal life. 
This dogma has been seriously challenged by several 
independent laboratories in recent years [4-5], even 
though some have expressed difference in opinion. 
 
While there has not been direct laboratory evidence in 
humans supporting or refuting the concept of germ cell 
renewal, our clinical and laboratory observations lend 
support to the existence of oocyte regeneration in 
human ovaries [6-7]. Ovarian cryopreservation is an 
experimental fertility preservation strategy which 
allows conservation of primordial follicle-rich ovarian 
tissue collected prior to gonadotoxic chemotherapy. 
After the completion of the cancer treatment and when 
fertility is desired, these tissues are thawed and 
transplanted back, enabling reversal of menopause.  We 
have  developed  and  performed  first  series  of ovarian  
 
 



















transplants in humans [8]. One of the ovarian 
transplantation techniques is transplantation of ovarian 
cortical strips under the skin [9]. In a cancer patient who 
became menopausal as a result of intense chemo-
therapy, we observed that transplantation of previously 
frozen ovarian cortical strips under the abdominal skin 
resulted in immediate reversal of menopause and four 
consecutive pregnancies with three live births [7]. This 
appeared to be the result of the activation of the 
remaining menopausal ovary in response to the 
transplantation of undamaged ovary under the skin. We 
speculated that chemotherapy is likely to damage the 
ovarian germ cell niche, as our earlier work suggested 
[2], resulting in the inability of the ovary to regenerate 
new oocytes. We surmised that the transplanted ovary 
provides the necessary regenerative signals from its 
niche to the preexisting ovary through the circulation, 
enabling this chemotherapy- damaged ovary to reinitiate 
oocyte generation (Figure 1).  
 
Our clinical observations are in line with the parabiotic 
model reported by Niikura et al [10], in this journal and 
with their earlier work on the role of ovarian niche in 
oocyte regeneration indicating that external factors in 
circulation can affect ovarian niche to reinstate oocyte 
production in the aging ovary. It is interesting that the 
regenerative signal originates from the aged male mice. 
One wonders if androgens have any role in the oocyte 
regenerative effect that Niikura et al observed. Perhaps 
higher androgen levels in the circulation from younger 
males are responsible for increased follicular atresia that 
the authors observed, as this is a known effect of potent 
androgens. As the androgen levels drop in the senescing 




















































become predominant, resulting in overall increase in 
primordial follicle reserve. This hypothesis is also 
consistent with recent clinical observations that weak 
androgens may be associated with improved ovarian 
follicle reserve. DHEAS, a weak androgen, is associated 
with improved ovarian response to fertility drugs and 
enhanced ovarian reserve in aging women [11], and 
Polycystic Ovarian Syndrome, a disease of ovulatory 
dysfunction and mildly increased androgens, is assoc-
iated with increased ovarian reserve [12]. 
 
As such the recent work by the Tilly laboratory [13] and 
our ongoing translational work open up a new frontier 
in the field of fertility preservation: manipulation of 
ovarian aging. The next era in fertility preservation 
research will be focusing on the pharmacological and 
genetic modifications in both slowing down oocyte 
attrition and enabling a healthier ovarian niche.  This 
will carry the aim to not only enrich the primordial 
follicle pool but also reverse age-induced alterations in 
oocyte quality and possibly curb age-related infertility 
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Figure 1. Hypothesis for spontaneous pregnancies after subcutaneous transplantation of ovarian tissues. Based on 
the work cited in this manuscript, we hypothesize that the transplanted healthy ovary provides the missing regenerative signals to 
peripheral niches and/or to the stromal niche in the remaining menopausal ovary that result in the resumption of neo-oogenesis.  
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